The Technical Analyst
Select Language :
Nektar Therapeutics [NKTR]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Nektar Therapeutics Price, Forecast, Insider, Ratings, Fundamentals & Signals

Nektar Therapeutics is listed at the  Exchange

5.55% $0.934

America/New_York / 28 mar 2024 @ 16:00


Nektar Therapeutics: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 171.54 mill
EPS: -1.450
P/E: -0.640
Earnings Date: May 06, 2024
SharesOutstanding: 183.62 mill
Avg Daily Volume: 1.616 mill
RATING 2024-03-28
B+
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Strong Buy
P/E: Sell
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.640 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.11x
Company: PE -0.640 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.849 - 1.019

( +/- 9.10%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-05 Deep Track Capital, Lp Buy 0 Common Stock
2024-02-20 Zalevsky Jonathan Sell 9 014 Common Stock
2024-02-20 Wilson Mark Andrew Sell 7 606 Common Stock
2024-02-20 Robin Howard W Sell 20 033 Common Stock
2023-12-13 Zalevsky Jonathan Buy 250 000 Stock Option
INSIDER POWER
84.82
Last 97 transactions
Buy: 6 976 063 | Sell: 637 451

Forecast: 16:00 - $0.940

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $0.940
Forecast 2: 16:00 - $0.940
Forecast 3: 16:00 - $0.940
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.934 (5.55% )
Volume 1.316 mill
Avg. Vol. 1.616 mill
% of Avg. Vol 81.43 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Nektar Therapeutics

Last 12 Months

Last 12 months chart data with high, low, open and close for Nektar Therapeutics

RSI

Intraday RSI14 chart for Nektar Therapeutics

Last 10 Buy & Sell Signals For NKTR

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Nektar Therapeutics

NKTR

Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, squamous cell carcinoma of the head and neck, and adjuvant melanoma; phase 2 clinical trial for the treatment of renal cell carcinoma, non-small cell lung cancer, and urothelial cancer; phase 1/2A clinical trial to treat squamous cell carcinoma of the head and neck; phase 1/2 clinical trial for the treatment of solid tumors; and phase 1B clinical trial to treat COVID-19. It is also developing NKTR-358, a cytokine Treg stimulant that is in phase 2 clinical trial for the treatment of systemic lupus erythematosus and ulcerative colitis, as well as phase 1B clinical trial to treat atopic dermatitis and psoriasis; NKTR-255, an IL-15 receptor agonist, which is in phase 1/2 clinical trial for the treatment of non-Hodgkin's lymphoma and multiple myeloma, and head and neck cancer and colorectal cancer; and NKTR-262, a toll-like receptor agonist that is in phase 1/2 clinical trial to treat solid tumors, as well as various other drug candidates. The company has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma S.A.; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; Amgen Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Baxalta Incorporated; Eli Lilly and Company; Merck KGaA; and SFJ Pharmaceuticals, Inc. Nektar Therapeutics was incorporated in 1990 and is headquartered in San Francisco, California.

Last 10 Buy Signals

Date Signal @
KSMUSDMar 29 - 01:38$48.53
BICOUSDMar 29 - 01:350.603
ETHWUSDMar 29 - 01:354.36
PERPUSDMar 29 - 01:361.423
LSKUSDMar 29 - 01:36$1.990
BNTUSDMar 29 - 01:36$0.881
OKBUSDMar 29 - 01:33$64.09
LRCUSDMar 29 - 01:35$0.387
WNEARUSDMar 29 - 01:337.04
DUSKUSDMar 29 - 01:310.578

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.